Inactive Instrument
CardieX Limited Stock OTC Markets
Stocks
CDEX.F
AU0000015729
Advanced Medical Equipment & Technology
OTC Markets Traded| Market Cap | 13.51M 9.46M 8.27M 7.65M 7.02M 13.28M 912M 91.22M 35.83M 445M 35.53M 34.75M 1.54B | P/E 2024 |
-2.06x | P/E 2025 | -0.78x |
|---|---|---|---|---|---|
| Enterprise Value | 14.71M 10.3M 9M 8.33M 7.64M 14.46M 993M 99.3M 39.01M 485M 38.68M 37.83M 1.67B | EV / Sales 2024 |
1.87x | EV / Sales 2025 | 3.83x |
| Free-Float |
65.49% | Yield 2024 * |
-
| Yield 2025 | - |
Last Transcript: CardieX Limited
| 24-07-17 | CardieX : Annual Report 202 | PU |
| 24-05-15 | CardieX : Stock Information | PU |
| 22-07-04 | CardieX : Application for quotation of securities - CDX | PU |
| 22-04-28 | CardieX : March Quarterly Activities Report | PU |
| 22-04-12 | CardieX : subsidiary files key regulatory submission for CONNEQT companion app | PU |
| Manager | Title | Age | Since |
|---|---|---|---|
Craig R. Cooper
CEO | Chief Executive Officer | - | - |
Sanjeev Bhavnani
CTO | Chief Tech/Sci/R&D Officer | - | 2024-02-29 |
Steven Kesten
CTO | Chief Tech/Sci/R&D Officer | 67 | - |
| Director | Title | Age | Since |
|---|---|---|---|
R. Nelson
BRD | Director/Board Member | 69 | 2015-11-12 |
Craig R. Cooper
BRD | Director/Board Member | - | 2017-11-30 |
Niall Cairns
CHM | Chairman | 62 | 2019-02-26 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -.--% | +166.67% | - | - | 9.91M | |
| +1.48% | +6.48% | +29.95% | +2.61% | 199B | |
| +2.10% | +7.46% | +6.30% | -14.77% | 142B | |
| +3.43% | -3.08% | -21.46% | +13.65% | 138B | |
| +3.67% | -0.42% | -56.88% | -15.86% | 63.97B | |
| +0.65% | -6.19% | +14.36% | -5.93% | 50.25B | |
| +1.18% | +2.66% | -23.86% | -31.97% | 44.33B | |
| +1.03% | +5.45% | +20.51% | +13.65% | 38.05B | |
| +0.87% | +2.73% | +30.61% | +39.67% | 36.81B | |
| +3.96% | +1.58% | -11.68% | -19.70% | 28.75B | |
| Average | +0.46% | -0.50% | -1.35% | -2.07% | 82.33B | |
| Weighted average by Cap. | -0.20% | +0.18% | +2.02% | -1.37% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | 12.81M 8.97M 7.84M 7.25M 6.65M 12.59M 864M 86.48M 33.97M 422M 33.69M 32.95M 1.46B | 6.05M 4.24M 3.7M 3.43M 3.14M 5.95M 408M 40.85M 16.05M 199M 15.91M 15.57M 688M |
| Net income | -6.77M -4.74M -4.14M -3.83M -3.51M -6.65M -456M -45.66M -17.94M -223M -17.79M -17.4M -769M | -18.19M -12.74M -11.13M -10.3M -9.45M -17.88M -1.23B -123M -48.24M -599M -47.84M -46.79M -2.07B |
| Net Debt | 3.35M 2.34M 2.05M 1.89M 1.74M 3.29M 226M 22.58M 8.87M 110M 8.8M 8.6M 381M | 1.2M 839K 733K 678K 622K 1.18M 80.85M 8.09M 3.18M 39.48M 3.15M 3.08M 136M |
Employees
-
Choose MarketScreener 
